These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35582988)

  • 1. Prevalence of SARS-CoV-2 antibodies during phased access to vaccination: results from a population-based survey in New York City, September 2020-March 2021.
    Parrott JC; Annibale AM; Osahan S; Alroy K; Caton JA; Chernov C; Dumas S; Fowler RC; Hermosi G; Hsin Y; Perlman S; Wu J; Hughes S; Gould LH; Schuster A
    Epidemiol Infect; 2022 May; 150():e105. PubMed ID: 35582988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of SARS-CoV-2 Antibodies in New York City Adults, June-October 2020: A Population-Based Survey.
    Parrott JC; Maleki AN; Vassor VE; Osahan S; Hsin Y; Sanderson M; Fernandez S; Levanon Seligson A; Hughes S; Wu J; DeVito AK; LaVoie SP; Rakeman JL; Gould LH; Alroy KA
    J Infect Dis; 2021 Jul; 224(2):188-195. PubMed ID: 34086923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Following the Largest Initial Epidemic Wave in the United States: Findings From New York City, 13 May to 21 July 2020.
    Pathela P; Crawley A; Weiss D; Maldin B; Cornell J; Purdin J; Schumacher PK; Marovich S; Li J; Daskalakis D;
    J Infect Dis; 2021 Jul; 224(2):196-206. PubMed ID: 33836067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the Period Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During the Omicron (BA.1) Surge in New York City (NYC), 1 January to 16 March 2022.
    Qasmieh SA; Robertson MM; Teasdale CA; Kulkarni SG; Nash D
    Clin Infect Dis; 2023 Feb; 76(3):e499-e502. PubMed ID: 35959571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of housing characteristics in racial and ethnic disparities in SARS-CoV-2 antibody seropositivity among New York City adults: A population representative study.
    Gouse I; Walters S; Miller-Archie S; Singh T; Lim S
    Prev Med; 2022 Nov; 164():107287. PubMed ID: 36208819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-Weighted Seroprevalence From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, Vaccination, and Hybrid Immunity Among US Blood Donations From January to December 2021.
    Busch MP; Stramer SL; Stone M; Yu EA; Grebe E; Notari E; Saa P; Ferg R; Manrique IM; Weil N; Fink RV; Levy ME; Green V; Cyrus S; Williamson PC; Haynes J; Groves J; Krysztof D; Custer B; Kleinman S; Biggerstaff BJ; Opsomer JD; Jones JM
    Clin Infect Dis; 2022 Oct; 75(Suppl 2):S254-S263. PubMed ID: 35684973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
    Jones JM; Stone M; Sulaeman H; Fink RV; Dave H; Levy ME; Di Germanio C; Green V; Notari E; Saa P; Biggerstaff BJ; Strauss D; Kessler D; Vassallo R; Reik R; Rossmann S; Destree M; Nguyen KA; Sayers M; Lough C; Bougie DW; Ritter M; Latoni G; Weales B; Sime S; Gorlin J; Brown NE; Gould CV; Berney K; Benoit TJ; Miller MJ; Freeman D; Kartik D; Fry AM; Azziz-Baumgartner E; Hall AJ; MacNeil A; Gundlapalli AV; Basavaraju SV; Gerber SI; Patton ME; Custer B; Williamson P; Simmons G; Thornburg NJ; Kleinman S; Stramer SL; Opsomer J; Busch MP
    JAMA; 2021 Oct; 326(14):1400-1409. PubMed ID: 34473201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronavirus Disease 2019 (COVID-19) Infection Among People With Human Immunodeficiency Virus in New York City: A Population-Level Analysis of Linked Surveillance Data.
    Braunstein SL; Lazar R; Wahnich A; Daskalakis DC; Blackstock OJ
    Clin Infect Dis; 2021 Jun; 72(12):e1021-e1029. PubMed ID: 33252620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of SARS-CoV-2 Antibodies in First Responders and Public Safety Personnel, New York City, New York, USA, May-July 2020.
    Sami S; Akinbami LJ; Petersen LR; Crawley A; Lukacs SL; Weiss D; Henseler RA; Vuong N; Mackey L; Patel A; Grohskopf LA; Morgenthau BM; Daskalakis D; Pathela P
    Emerg Infect Dis; 2021 Mar; 27(3):796-804. PubMed ID: 33493106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.
    Murhekar MV; Bhatnagar T; Selvaraju S; Saravanakumar V; Thangaraj JWV; Shah N; Kumar MS; Rade K; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Khan SMS; Kumar CPG; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Mohanty SS; Rangaraju C; Turuk A; Baradwaj DK; Chahal AS; Debnath F; Haq I; Kalliath A; Kanungo S; Kshatri JS; Lakshmi GGJN; Mitra A; Nirmala AR; Prasad GV; Qurieshi MA; Sahay S; Sangwan RK; Sekar K; Shukla VK; Singh PK; Singh P; Singh R; Varma DS; Viramgami A; Panda S; Reddy DCS; Bhargava B;
    Lancet Glob Health; 2021 Mar; 9(3):e257-e266. PubMed ID: 33515512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection, cases due to SARS-CoV-2 in rural areas during early COVID-19 vaccination: findings from serosurvey study in a rural cohort of eastern India.
    Dash P; Mansingh A; Nayak SR; Sahoo D; Bhattacharya D; Kanungo S; Kshatri JS; Mishra BK; Pattnaik M; Parai D; Choudhary HR; Nayak S; Rana K; Alice A; Sahoo AK; Mohanty KC; Mohanty P; Doley C; Jain H; Majhi D; Pattanayak P; Behuria S; Panda S; Bhoi S; Pati S; Palo SK
    Epidemiol Infect; 2022 Mar; 150():e58. PubMed ID: 35287778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Seroprevalence Among Healthcare Workers by Job Function and Work Location in a New York Inner-City Hospital.
    Purswani MU; Bucciarelli J; Tiburcio J; Yagudayev SM; Connell GH; Omidiran AA; Hannaway L; Zeana C; Healy M; Yu G; Reich D
    J Hosp Med; 2021 May; 16(5):282-289. PubMed ID: 33929948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020-2023.
    Carreño JM; Wagner AL; Monahan B; Singh G; Floda D; Gonzalez-Reiche AS; Tcheou J; Raskin A; Bielak D; Morris S; Fried M; Yellin T; Sullivan L; ; Sordillo EM; Gordon A; van Bakel H; Simon V; Krammer F
    Nat Commun; 2024 Jul; 15(1):5847. PubMed ID: 38992013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021.
    Raqib R; Sarker P; Akhtar E; Nurul Huda TM; Haq MA; Roy AK; Hosen MB; Haque F; Chowdhury MR; Reidpath DD; Emdadul Hoque DM; Islam Z; Ahmed S; Ahmed T; Tofail F; Razzaque A
    PLoS One; 2022; 17(5):e0268093. PubMed ID: 35604947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced COVID-19 hospitalizations among New York City residents following age-based SARS-CoV-2 vaccine eligibility: Evidence from a regression discontinuity design.
    Greene SK; Levin-Rector A; McGibbon E; Baumgartner J; Devinney K; Ternier A; Sell J; Kahn R; Kishore N
    Vaccine X; 2022 Apr; 10():100134. PubMed ID: 34961848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of SARS-CoV-2 Seropositivity During the First and Second Viral Waves in 2020 and 2021 Among Canadian Adults.
    Tang X; Sharma A; Pasic M; Brown P; Colwill K; Gelband H; Birnboim HC; Nagelkerke N; Bogoch II; Bansal A; Newcombe L; Slater J; Rodriguez PS; Huang G; Fu SH; Meh C; Wu DC; Kaul R; Langlois MA; Morawski E; Hollander A; Eliopoulos D; Aloi B; Lam T; Abe KT; Rathod B; Fazel-Zarandi M; Wang J; Iskilova M; Pasculescu A; Caldwell L; Barrios-Rodiles M; Mohammed-Ali Z; Vas N; Santhanam DR; Cho ER; Qu K; Jha S; Jha V; Suraweera W; Malhotra V; Mastali K; Wen R; Sinha S; Reid A; Gingras AC; Chakraborty P; Slutsky AS; Jha P;
    JAMA Netw Open; 2022 Feb; 5(2):e2146798. PubMed ID: 35171263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Prevalence of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (Anti-SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey.
    Nkuba AN; Makiala SM; Guichet E; Tshiminyi PM; Bazitama YM; Yambayamba MK; Kazenza BM; Kabeya TM; Matungulu EB; Baketana LK; Mitongo NM; Thaurignac G; Leendertz FH; Vanlerberghe V; Pelloquin R; Etard JF; Maman D; Mbala PK; Ayouba A; Peeters M; Muyembe JT; Delaporte E; Ahuka SM
    Clin Infect Dis; 2022 Mar; 74(5):882-890. PubMed ID: 34089598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of SARS-CoV-2 IgG Antibodies and Factors Associated with SARS-CoV-2 IgG Neutralizing Activity among Primary Health Care Workers 6 Months after Vaccination Rollout in France.
    Decarreaux D; Pouquet M; Souty C; Vilcu AM; Prévot-Monsacre P; Fourié T; Villarroel PMS; Priet S; Blanché H; Sebaoun JM; Deleuze JF; Turbelin C; Werner A; Kochert F; Grosgogeat B; Rabiega P; Laupie J; Abraham N; Guerrisi C; Noël H; Van der Werf S; Carrat F; Hanslik T; Charrel R; De Lamballerie X; Blanchon T; Falchi A
    Viruses; 2022 May; 14(5):. PubMed ID: 35632699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of São Paulo, Brazil.
    Tess BH; Granato CFH; Alves MCGP; Pintão MCT; Nunes MC; Rizzatti EG; Reinach FC
    Braz J Infect Dis; 2021; 25(4):101604. PubMed ID: 34416142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.